What does DR KATRIEN BAGGERMAN do?

DR KATRIEN BAGGERMAN is a specialist medical practice in Keerbergen. Private Limited, started on 1 April 2009, 1 establishment.

What is the address of DR KATRIEN BAGGERMAN?

The registered office of DR KATRIEN BAGGERMAN is located at Rijmenamsebaan 2f, 3140 Keerbergen.

Is DR KATRIEN BAGGERMAN still active?

Yes. According to the CBE (18 September 2026) DR KATRIEN BAGGERMAN is active, legal situation “Normale toestand”, started on 1 April 2009.

Is DR KATRIEN BAGGERMAN registered on Peppol?

Yes, DR KATRIEN BAGGERMAN is registered on the Peppol network with ID 0208:0810843190.

What is the enterprise number of DR KATRIEN BAGGERMAN?

The enterprise number of DR KATRIEN BAGGERMAN is BE0810843190.

When was DR KATRIEN BAGGERMAN founded?

DR KATRIEN BAGGERMAN was founded on 1 April 2009.

Who are the directors of DR KATRIEN BAGGERMAN?

According to the 2025 annual accounts, the directors of DR KATRIEN BAGGERMAN are: Katrien BAGGERMAN.

Is DR KATRIEN BAGGERMAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 April 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR KATRIEN BAGGERMAN make in 2025?

DR KATRIEN BAGGERMAN posted a profit after taxes of € 93,895 in financial year 2025.

What is the revenue of DR KATRIEN BAGGERMAN?

As a small company, DR KATRIEN BAGGERMAN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 111,873.

DR KATRIEN BAGGERMAN (Private Limited) - Keerbergen

Dossier DR KATRIEN BAGGERMAN, printed on 18 September 2026 from databakkes.be/en/0810843190/dr-katrien-baggerman. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR KATRIEN BAGGERMAN from Keerbergen, company number BE0810843190, closed financial year 2025 with a result of € 93,895 after tax. For that financial year DR KATRIEN BAGGERMAN recorded a gross margin of € 111,873 and equity of € 305,647. Compared with financial year 2024, the result moved from € 77,760 to € 93,895. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 305,647

▲ 44% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 93,895

▲ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 145,649

▲ 201% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 293,247.

People and assets in 2025

Wage cost

€ 2,500

▲ 51% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 45,362

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 44,683

▼ 23% vs 2024

€ 14,031 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 9,228

▲ 248% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 3,996

▲ 163% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 25,057 Gross margin 2022: € 25,057 First fiscal year in the series	€ 101,585 Gross margin 2023: € 101,585 ▲ € 76,528 vs 2022 (€ 25,057) Favourable step	€ 102,609 Gross margin 2024: € 102,609 ▲ 1% vs 2023 (€ 101,585) Favourable step	€ 111,873 Gross margin 2025: € 111,873 ▲ 9% vs 2024 (€ 102,609) Favourable step	▲ 9%
Profit after taxes	€ 13,027 Profit after taxes 2022: € 13,027 First fiscal year in the series	€ 66,009 Profit after taxes 2023: € 66,009 ▲ € 52,982 vs 2022 (€ 13,027) Favourable step	€ 77,760 Profit after taxes 2024: € 77,760 ▲ 18% vs 2023 (€ 66,009) Favourable step	€ 93,895 Profit after taxes 2025: € 93,895 ▲ 21% vs 2024 (€ 77,760) Favourable step	▲ 21%
Equity	€ 137,953 Equity 2022: € 137,953 First fiscal year in the series	€ 161,866 Equity 2023: € 161,866 ▲ 17% vs 2022 (€ 137,953) Favourable step	€ 211,752 Equity 2024: € 211,752 ▲ 31% vs 2023 (€ 161,866) Favourable step	€ 305,647 Equity 2025: € 305,647 ▲ 44% vs 2024 (€ 211,752) Favourable step	▲ 44%
Total debts	€ 88,354 Total debts 2022: € 88,354 First fiscal year in the series	€ 126,498 Total debts 2023: € 126,498 ▲ 43% vs 2022 (€ 88,354) Unfavourable step	€ 116,063 Total debts 2024: € 116,063 ▼ 8% vs 2023 (€ 126,498) Favourable step	€ 87,209 Total debts 2025: € 87,209 ▼ 25% vs 2024 (€ 116,063) Favourable step	▼ 25%
Cash	€ 76,010 Cash 2022: € 76,010 First fiscal year in the series	€ 93,576 Cash 2023: € 93,576 ▲ 23% vs 2022 (€ 76,010) Favourable step	€ 48,338 Cash 2024: € 48,338 ▼ 48% vs 2023 (€ 93,576) Unfavourable step	€ 145,649 Cash 2025: € 145,649 ▲ 201% vs 2024 (€ 48,338) Favourable step	▲ 201%
Land & buildings	€ 35,361 Land & buildings 2022: € 35,361 First fiscal year in the series	€ 32,250 Land & buildings 2023: € 32,250 ▼ 9% vs 2022 (€ 35,361) Unchanged	€ 30,100 Land & buildings 2024: € 30,100 ▼ 7% vs 2023 (€ 32,250) Unchanged	€ 27,950 Land & buildings 2025: € 27,950 ▼ 7% vs 2024 (€ 30,100) Unchanged	▼ 7%
Retained profit	€ 125,553 Retained profit 2022: € 125,553 First fiscal year in the series	€ 149,466 Retained profit 2023: € 149,466 ▲ 19% vs 2022 (€ 125,553) Favourable step	€ 199,352 Retained profit 2024: € 199,352 ▲ 33% vs 2023 (€ 149,466) Favourable step	€ 293,247 Retained profit 2025: € 293,247 ▲ 47% vs 2024 (€ 199,352) Favourable step	▲ 47%
Dividend	€ 30,526 Dividend 2022: € 30,526 First fiscal year in the series	€ 42,097 Dividend 2023: € 42,097 ▲ 38% vs 2022 (€ 30,526) Unchanged	€ 27,874 Dividend 2024: € 27,874 ▼ 34% vs 2023 (€ 42,097) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 27,874) Unchanged	▼ 100%
Bank debt	€ 42,519 Bank debt 2022: € 42,519 First fiscal year in the series	€ 71,182 Bank debt 2023: € 71,182 ▲ 67% vs 2022 (€ 42,519) Unfavourable step	€ 58,186 Bank debt 2024: € 58,186 ▼ 18% vs 2023 (€ 71,182) Favourable step	€ 44,683 Bank debt 2025: € 44,683 ▼ 23% vs 2024 (€ 58,186) Favourable step	▼ 23%
Balance sheet total	€ 226,308 Balance sheet total 2022: € 226,308 First fiscal year in the series	€ 288,364 Balance sheet total 2023: € 288,364 ▲ 27% vs 2022 (€ 226,308) Unchanged	€ 327,814 Balance sheet total 2024: € 327,814 ▲ 14% vs 2023 (€ 288,364) Unchanged	€ 392,856 Balance sheet total 2025: € 392,856 ▲ 20% vs 2024 (€ 327,814) Unchanged	▲ 20%

Key figures of DR KATRIEN BAGGERMAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR KATRIEN BAGGERMAN?

What happened at DR KATRIEN BAGGERMAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 93,895 (▲ 21% vs 2024). filed late Source: NBB ↗
2019 Katrien BAGGERMAN became a director. NBB
Apr 1, 2009 Start of the company according to the CBE. KBO
Mar 27, 2009 New establishment in Keerbergen. KBO

In short

From € 13,027 profit in 2022 to € 93,895 profit in 2025.

Paid € 104,232 in corporate taxes since 2022.

Best year ever: 2025, with € 93,895 profit.

Paid out € 100,497 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR KATRIEN BAGGERMAN? We notify you, reason included.

Follow DR KATRIEN BAGGERMAN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Katrien BAGGERMAN

DR KATRIEN BAGGERMAN

Behind DR KATRIEN BAGGERMAN is Katrien BAGGERMAN.

See the full network in the app

Directors

According to the 2025 annual accounts

Katrien BAGGERMAN

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Rijmenamsebaan 2f

3140 Keerbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0810.843.190
VAT number: BE 0810.843.190
Registered office: Rijmenamsebaan 2f, 3140 Keerbergen
Names & denominations: DR KATRIEN BAGGERMAN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 April 2009
Peppol: Active · Active since 13 Jan 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗